Samuel Eric Wilson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Samuel Eric Wilson has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Arthur W. Hatfield
2 shared publicationsEdward Hansen
2 shared publications- Ian L. Gordon
Department of Surgery, University of California, Irvine, USA
2 shared publications Juan Carlos Jimenez
2 shared publicationsPaul N. Suding
2 shared publicationsWilliam McMaster
2 shared publications
Latest Publications
- 1 June 2009
- Published by SAGE Publications in Surgical Infections
- Vol. 10 (3) , 285-288
Is There a Current Role for Preoperative Non-Absorbable Oral Antimicrobial Agents for Prophylaxis of Infection after Colorectal Surgery?
Background: In numerous scientific studies, oral antibiotic bowel preparation has reduced surgical site infections in patients undergoing colorectal surgery. The historical evolution of antibiotic bowel preparation is presented with a review of the scientific basis of its effectiveness. Methods: Review of the pertinent English language literature. Results: Successful oral antibiotic bowel preparation requires effective mechanical preparation. The progressive shift of preoperative preparation to the outpatient setting has led to a reduction in the use of oral antibiotics. Such preparation, however, continues to be effective although in current surgical practice is often augmented with perioperative, parenteral antimicrobials. Conclusion: Oral antibiotic bowel preparation has a role in the prevention of surgical site infection in the patient undergoing colorectal surgery.
- 1 June 2009
- Published by SAGE Publications in Surgical Infections
- Vol. 10 (3) , 285-288
Is There a Current Role for Preoperative Non-Absorbable Oral Antimicrobial Agents for Prophylaxis of Infection after Colorectal Surgery?
Background: In numerous scientific studies, oral antibiotic bowel preparation has reduced surgical site infections in patients undergoing colorectal surgery. The historical evolution of antibiotic bowel preparation is presented with a review of the scientific basis of its effectiveness. Methods: Review of the pertinent English language literature. Results: Successful oral antibiotic bowel preparation requires effective mechanical preparation. The progressive shift of preoperative preparation to the outpatient setting has led to a reduction in the use of oral antibiotics. Such preparation, however, continues to be effective although in current surgical practice is often augmented with perioperative, parenteral antimicrobials. Conclusion: Oral antibiotic bowel preparation has a role in the prevention of surgical site infection in the patient undergoing colorectal surgery.
- 15 September 2008
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 143 (9) , 907-912
Definitive Risk Factors for Anastomotic Leaks in Elective Open Colorectal Resection
Research from JAMA Surgery — Definitive Risk Factors for Anastomotic Leaks in Elective Open Colorectal Resection
- 15 September 2008
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 143 (9) , 907-912
Definitive Risk Factors for Anastomotic Leaks in Elective Open Colorectal Resection
Research from JAMA Surgery — Definitive Risk Factors for Anastomotic Leaks in Elective Open Colorectal Resection
- 30 April 2008
- Published by Elsevier in Annales de Chirurgie Vasculaire
- Vol. 22 (2) , 208-213
Les interventions endovasculaires diminuent le nombre de pontages des membres inférieurs sans augmenter le taux d'amputations majeures
- 30 April 2008
- Published by Elsevier in Annales de Chirurgie Vasculaire
- Vol. 22 (2) , 208-213
Les interventions endovasculaires diminuent le nombre de pontages des membres inférieurs sans augmenter le taux d'amputations majeures
- 1 March 2008
- Published by Elsevier in Anales de Cirugía Vascular
- Vol. 22 (2) , 209-214
El aumento de las intervenciones endovasculares disminuye la tasa de derivaciones arteriales en la extremidad inferior sin incremento de la tasa de amputaciones mayores
- 1 March 2008
- Published by Elsevier in Anales de Cirugía Vascular
- Vol. 22 (2) , 209-214
El aumento de las intervenciones endovasculares disminuye la tasa de derivaciones arteriales en la extremidad inferior sin incremento de la tasa de amputaciones mayores
- 1 November 2007
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 142 (11) , 1102
Intraoperative Autotransfusion in Abdominal Aortic Aneurysm Surgery: Meta-analysis of Randomized Controlled Trials—Invited Critique
- 1 November 2007
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 142 (11) , 1102
Intraoperative Autotransfusion in Abdominal Aortic Aneurysm Surgery: Meta-analysis of Randomized Controlled Trials—Invited Critique
- Open Access
- 1 July 2002
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (1) , 62-68
Intra‐abdominal Sepsis in Elderly Persons
Elderly patients represent a greater percentage of the population now than ever before, with 12.4% of North Americans being µ65 years of age. Intra-a
- 1 July 2002
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 35 (1) , 62-68
Open AccessIntra‐abdominal Sepsis in Elderly Persons
Elderly patients represent a greater percentage of the population now than ever before, with 12.4% of North Americans being µ65 years of age. Intra-a
- 1 June 2001
- Published by SAGE Publications in Surgical Infections
- Vol. 2 (2) , 171-177
New Alternatives in Management of the Infected Vascular Prosthesis
Background: Infection of vascular prosthetics implanted for arterial occlusive disease occurs in approximately 1-5% of patients, including early and late clinical presentation. The incidence of infection depends on the anatomical site, with the highest rate occurring in vascular access grafts placed for hemodialysis and in inguinal and lower extremity incisions in patients undergoing bypass procedures for femoropopliteal tibial occlusion. Treatment of prosthetic graft infection has traditionally included antimicrobials, excision of the infected prosthesis, and extraanatomical bypass. With the recognition that prosthetic infection secondary to Staphylococcus epidermidis can be managed with less extensive procedures, clinical data have been reported on in situ replacement with antibiotic-bonded prostheses. Patients who have S. aureus isolated, including methicillin-resistant S. aureus, or gram-negative pathogens, still require conventional graft excision and extraanatomical bypass. Methods: Selective review of the English-language literature. Results: Recent clinical series show that management by graft excision of infected infrarenal aortic prosthetics and axillofemoral bypass results in 2- and 5-year survival rates of 67% and 47%, and limb salvage rates in survivors of 93% and 82% at 2 and 5 years. In situ replacement with a rifampicin-bonded prosthesis has been accomplished successfully in smaller numbers of patients and shows promising early results. Other methods under study include cryopreserved arterial and femoral vein allografts and autogenous femoral vein grafts, but data are limited when used as replacement for infected prosthetics. Conclusion: Advances in the management of infected vascular prostheses over the last decade have led to improved mortality and decreased amputation rates with conventional excision and extraanatomical bypass. Newer methods including in situ graft replacement with antibiotic-impregnated prosthetics appear suitable for low-virulence S. epidermidis infection. Early results are promising for cryopreserved allografts and autogenous femoral vein in situ grafts; however, more clinical experience and longer follow-up will be needed to confirm their durability in a contaminated field.
- 1 June 2001
- Published by SAGE Publications in Surgical Infections
- Vol. 2 (2) , 171-177
New Alternatives in Management of the Infected Vascular Prosthesis
Background: Infection of vascular prosthetics implanted for arterial occlusive disease occurs in approximately 1-5% of patients, including early and late clinical presentation. The incidence of infection depends on the anatomical site, with the highest rate occurring in vascular access grafts placed for hemodialysis and in inguinal and lower extremity incisions in patients undergoing bypass procedures for femoropopliteal tibial occlusion. Treatment of prosthetic graft infection has traditionally included antimicrobials, excision of the infected prosthesis, and extraanatomical bypass. With the recognition that prosthetic infection secondary to Staphylococcus epidermidis can be managed with less extensive procedures, clinical data have been reported on in situ replacement with antibiotic-bonded prostheses. Patients who have S. aureus isolated, including methicillin-resistant S. aureus, or gram-negative pathogens, still require conventional graft excision and extraanatomical bypass. Methods: Selective review of the English-language literature. Results: Recent clinical series show that management by graft excision of infected infrarenal aortic prosthetics and axillofemoral bypass results in 2- and 5-year survival rates of 67% and 47%, and limb salvage rates in survivors of 93% and 82% at 2 and 5 years. In situ replacement with a rifampicin-bonded prosthesis has been accomplished successfully in smaller numbers of patients and shows promising early results. Other methods under study include cryopreserved arterial and femoral vein allografts and autogenous femoral vein grafts, but data are limited when used as replacement for infected prosthetics. Conclusion: Advances in the management of infected vascular prostheses over the last decade have led to improved mortality and decreased amputation rates with conventional excision and extraanatomical bypass. Newer methods including in situ graft replacement with antibiotic-impregnated prosthetics appear suitable for low-virulence S. epidermidis infection. Early results are promising for cryopreserved allografts and autogenous femoral vein in situ grafts; however, more clinical experience and longer follow-up will be needed to confirm their durability in a contaminated field.
- 1 March 2001
- Published by SAGE Publications in Surgical Infections
- Vol. 2 (1) , 25-35
Clinical Trial Results with Linezolid, an Oxazolidinone, in the Treatment of Soft Tissue and Postoperative Gram-Positive Infections
Background: Infectious complications encountered after major surgery include operative site infections and nosocomial pneumonia. Recent infection surveillance programs have identified the increasing pathogenic role of gram-positive bacteria in these infections and the high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the United States and abroad. Surgical site infections and nosocomial pneumonia, often serious infections, are associated with adverse clinical outcomes including bacteremia and its resultant complications, as well as the socioeconomic consequences of excess hospitalization and discharge to nursing care. Methods: The essential triad for management of postoperative soft tissue infection consists of thorough appraisal of the infection site for reintervention, culture of drainage or infected tissue, and prompt initiation of empiric antimicrobial therapy designed to cover the most probable causative pathogens. Broad-spectrum antimicrobial regimens are often necessary for empiric therapy of skin and soft tissue infections or nosocomial pneumonia; however, regimens should be tailored to the most effective and clinically appropriate agent based on results of susceptibility testing. Results: Results of the clinical trial experience with the first United States Food and Drug Administration (FDA)-approved antimicrobial in the new class of oxazolidinones, linezolid, are reviewed. Conclusion: In randomized, controlled trials, linezolid 600 mg twice daily (intravenously or orally) provided effective antimicrobial therapy for gram-positive soft tissue infections, including MRSA, and nosocomial pneumonia in which S. aureus was a causative pathogen.
- 1 March 2001
- Published by SAGE Publications in Surgical Infections
- Vol. 2 (1) , 25-35
Clinical Trial Results with Linezolid, an Oxazolidinone, in the Treatment of Soft Tissue and Postoperative Gram-Positive Infections
Background: Infectious complications encountered after major surgery include operative site infections and nosocomial pneumonia. Recent infection surveillance programs have identified the increasing pathogenic role of gram-positive bacteria in these infections and the high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the United States and abroad. Surgical site infections and nosocomial pneumonia, often serious infections, are associated with adverse clinical outcomes including bacteremia and its resultant complications, as well as the socioeconomic consequences of excess hospitalization and discharge to nursing care. Methods: The essential triad for management of postoperative soft tissue infection consists of thorough appraisal of the infection site for reintervention, culture of drainage or infected tissue, and prompt initiation of empiric antimicrobial therapy designed to cover the most probable causative pathogens. Broad-spectrum antimicrobial regimens are often necessary for empiric therapy of skin and soft tissue infections or nosocomial pneumonia; however, regimens should be tailored to the most effective and clinically appropriate agent based on results of susceptibility testing. Results: Results of the clinical trial experience with the first United States Food and Drug Administration (FDA)-approved antimicrobial in the new class of oxazolidinones, linezolid, are reviewed. Conclusion: In randomized, controlled trials, linezolid 600 mg twice daily (intravenously or orally) provided effective antimicrobial therapy for gram-positive soft tissue infections, including MRSA, and nosocomial pneumonia in which S. aureus was a causative pathogen.